What is Enovis's cash and cash equivalents, end of period?

Enovis (ENOV) reported cash and cash equivalents, end of period of $33.13M in Q1 2026.

How has Enovis's cash and cash equivalents, end of period changed year-over-year?

Enovis's cash and cash equivalents, end of period decreased by 13.9% year-over-year, from $38.46M to $33.13M.

What is the long-term trend for Enovis's cash and cash equivalents, end of period?

Over 5 years (2020 to 2025), Enovis's cash and cash equivalents, end of period has grown at a -18.5% compound annual growth rate (CAGR), from $101.07M to $36.39M.

Enovis ENOV Cash and cash equivalents, end of period

Cash and cash equivalents, end of period at other companies

Baxter InternationalBAX

——

Select Medical HoldingsSEM

——

Other financials

Income statement

See full

Revenue$589.2M+5.4%

Gross profit$365.5M+10.0%

Operating income$6.5M+114%

Net income-$8.8M+84.3%

EPS (diluted)-$0.15+84.7%

Balance sheet

See full

Cash & equivalents$33.1M-13.9%

Total debt$1.4B-3.1%

Total equity$1.5B-43.6%

Total assets$3.8B-21.4%

Cash flow

See full

Operating cash flow$24.0M+1,601%

CapEx$52.8M+22.1%

Free cash flow-$28.9M+35.7%

Valuation

See full

Market cap$1.27B-26.3%

Enterprise value$2.59B-16.0%

P/S0.6×-0.2×

Profitability

See full

Gross margin60.5%+4.0pp

Operating margin-47%+18.6pp

Net margin-49.9%+24.1pp

FCF margin-3.1%-1.1pp

Returns & leverage

See full

Return on equity-55.5%-1,722pp

Debt / equity0.9×+0.4×

Current ratio2×-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's cash and cash equivalents, end of period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Enovis's cash and cash equivalents, end of period?: Enovis (ENOV) reported cash and cash equivalents, end of period of $33.13M in Q1 2026.
How has Enovis's cash and cash equivalents, end of period changed year-over-year?: Enovis's cash and cash equivalents, end of period decreased by 13.9% year-over-year, from $38.46M to $33.13M.
What is the long-term trend for Enovis's cash and cash equivalents, end of period?: Over 5 years (2020 to 2025), Enovis's cash and cash equivalents, end of period has grown at a -18.5% compound annual growth rate (CAGR), from $101.07M to $36.39M.